Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | Sr. VP, Gen Counsel, and Sec. | June 15, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 35,259 |
Reported balance
After 2026-06-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-15 · Sale · Disposed 1,419 · Balance 35,259 F1: As of June 15, 2026, 8,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: As of June 15, 2026, 8,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 30,796 · Balance 0 F1: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2023-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 3,000 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 12,252 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 12,252 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 8,000 · Balance 0 F5: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 15,000 · Balance 0 F6: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 14,000 · Balance 0 F7: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 21,536 · Balance 0 F8: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 21,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 12,252 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 21,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 16, 2026 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,419 | $209.28 | $296,968.32 |
DisclosureSEC source: 0001628280-26-043561 · wk-form4_1781641870.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,259 F1 · balance_after: As of June 15, 2026, 8,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 401 | $212.24 | $85,108.24 |
DisclosureSEC source: 0001628280-26-041640 · wk-form4_1780950796.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,678 F1 · shares: 401 shares were withheld from the 1,376 restricted shares that vested on June 4, 2026. These 401 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026. F2 · balance_after: As of June 8, 2026, 8,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 365 | $210.19 | $76,719.35 |
DisclosureSEC source: 0001628280-26-041284 · wk-form4_1780691595.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,079 F1 · shares: 365 shares were withheld from the 1,252 restricted shares that vested on June 3, 2026. These 365 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 3, 2026. F2 · balance_after: As of June 3, 2026, 9,615 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,376 on June 4, 2026; 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:35 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 15,200 | $0.00 Strike: $230.74 | $0.00 |
DisclosureSEC source: 0001628280-26-040848 · wk-form4_1780605304.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,200 Underlying: Ordinary Shares · 15,200 shares Expires 2036-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,800 on June 2, 2027, 3,800 on June 2, 2028, 3,800 on June 4, 2029 and 3,800 on June 3, 2030. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 247 | $209.76 | $51,810.72 |
DisclosureSEC source: 0001628280-26-040848 · wk-form4_1780605304.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,444 F2 · shares: 247 shares were withheld from the 846 restricted shares that vested on June 2, 2026. These 247 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 10,867 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:35 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 4,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040848 · wk-form4_1780605304.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,691 F1 · balance_after: As of June 2, 2026, 10,867 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:42 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 337 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040445 · wk-form4_1780519337.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,332 F1 · shares: 337 shares were withheld from the 1,157 restricted shares that vested on June 1, 2026. These 337 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 7,354 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:34 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001628280-25-052076 · wk-form4_1763069671.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 15,000 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 15,000 ordinary shares for $69.72 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 15,000 | $265.14 | $3,977,100.00 |
DisclosureSEC source: 0001628280-25-052076 · wk-form4_1763069671.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,669 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $265.00 to $265.95 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: As of November 11, 2025, 8,511 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:34 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 15,000 | $69.72 | $1,045,800.00 |
DisclosureSEC source: 0001628280-25-052076 · wk-form4_1763069671.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of November 11, 2025, 8,511 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:53 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-044120 · wk-form4_1759524783.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,669 F1 · shares: 91 shares were withheld from the 202 restricted shares that vested on October 1, 2025 These 91 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 202 ordinary shares were awarded to Mr. Zangerle on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. F2 · balance_after: As of October 1, 2025, 8,511 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,648 | $241.61 | $398,173.28 |
DisclosureSEC source: 0001628280-25-031870 · wk-form4_1750192470.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,760 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $241.28 to $241.815 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of June 13, 2025, 8,713 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 330 | $240.63 | $79,407.90 |
DisclosureSEC source: 0001628280-25-031870 · wk-form4_1750192470.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,408 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $240.20 to $241.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of June 13, 2025, 8,713 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:31 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 425 | $242.10 | $102,892.50 |
DisclosureSEC source: 0001628280-25-030027 · wk-form4_1749241883.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,738 F1 · shares: 425 shares were withheld from the 1,376 restricted shares that vested on June 4, 2025. These 425 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,376 ordinary shares were awarded to Mr. Zangerle on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. F2 · balance_after: As of June 4, 2025, 8,713 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:39 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 13,360 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029689 · wk-form4_1749155829.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,360 Underlying: Ordinary Shares · 13,360 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 3,340 on June 3, 2026, 3,340 on June 3, 2027, 3,340 on June 5, 2028 and 3,340 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:39 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029689 · wk-form4_1749155829.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,163 F1 · balance_after: As of June 3, 2025, 10,089 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 253 | $242.08 | $61,246.24 |
DisclosureSEC source: 0001628280-25-029365 · wk-form4_1749069445.xml · nonDerivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,407 F4 · shares: 253 shares were withheld from the 846 restricted shares that vested on June 2, 2025. These 253 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 846 ordinary shares were awarded to Mr. Zangerle on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 6,333 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 245 | $242.08 | $59,309.60 |
DisclosureSEC source: 0001628280-25-029365 · wk-form4_1749069445.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,660 F3 · shares: 245 shares were withheld from the 819 restricted shares that vested on June 2, 2025. These 245 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 819 ordinary shares were awarded to Mr. Zangerle on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 6,333 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 346 | $242.08 | $83,759.68 |
DisclosureSEC source: 0001628280-25-029365 · wk-form4_1749069445.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,905 F1 · shares: 346 shares were withheld from the 1,157 restricted shares that vested on June 2, 2025. These 346 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,157 ordinary shares were awarded to Mr. Zangerle on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 6,333 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 91 | $235.78 | $21,455.98 |
DisclosureSEC source: 0001628280-24-041932 · wk-form4_1727901421.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,251 F1 · shares: 91 shares were withheld from the 202 restricted shares that vested on October 1, 2024. These 91 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 202 ordinary shares were awarded to Mr. Zangerle on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 9,155 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 15,684 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027084 · wk-form4_1717706244.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,684 Underlying: Ordinary Shares · 15,684 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 3,921 on June 4, 2025; 3,921 on June 4, 2026; 3,921 on June 4, 2027 and 3,921 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 4,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027084 · wk-form4_1717706244.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,342 F1 · balance_after: As of June 4, 2024, 9,357 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 253 | $228.37 | $57,777.61 |
DisclosureSEC source: 0001628280-24-026875 · wk-form4_1717619814.xml · nonDerivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,214 F3 · shares: 253 shares were withheld from the 846 restricted shares that vested on June 3, 2024. These 253 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 846 ordinary shares were awarded to Mr. Zangerle on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024 5,229 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 245 | $228.37 | $55,950.65 |
DisclosureSEC source: 0001628280-24-026875 · wk-form4_1717619814.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,467 F2 · shares: 245 shares were withheld from the 819 restricted shares that vested on June 3, 2024. These 245 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 819 ordinary shares were awarded to Mr. Zangerle on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 225 | $228.37 | $51,383.25 |
DisclosureSEC source: 0001628280-24-026875 · wk-form4_1717619814.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,712 F1 · shares: 225 shares were withheld from the 752 restricted shares that vested on June 3, 2024. These 225 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 752 ordinary shares were awarded to Mr. Zangerle on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:40 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 346 | $222.88 | $77,116.48 |
DisclosureSEC source: 0001628280-24-026600 · wk-form4_1717533597.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,937 F1 · shares: 346 shares were withheld from the 1,157 restricted shares that vested on May 31, 2024. These 346 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,157 ordinary shares were awarded to Mr. Zangerle on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 7,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 61 | $215.50 | $13,145.50 |
DisclosureSEC source: 0001209191-23-051988 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,283 F1 · shares: 61 shares were withheld from the 202 restricted shares that vested on October 2, 2023. These 61 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 202 ordinary shares were awarded to Mr. Zangerle on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. F2 · balance_after: As of October 2, 2023, 8,803 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on May 31, 2024; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:30 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 498 | $205.47 | $102,324.06 |
DisclosureSEC source: 0001209191-23-034763 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,344 F1 · shares: 498 shares were withheld from the 1,665 restricted shares that vested on June 2, 2023. These 498 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,665 ordinary shares were awarded to Mr. Zangerle on June 2, 2021 and June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2023. F2 · balance_after: As of June 2, 2023, 9,005 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 2, 2023; 1,157 on May 31, 2024; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:30 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 225 | $202.42 | $45,544.50 |
DisclosureSEC source: 0001209191-23-034305 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,842 F1 · shares: 225 shares were withheld from the 752 restricted shares that vested on June 1, 2023. These 225 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 752 ordinary shares were awarded to Mr. Zangerle on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2023. F2 · balance_after: As of June 1, 2023, 10,670 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 1,157 on May 31, 2024; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 19,480 | $0.00 Strike: $219.97 | $0.00 |
DisclosureSEC source: 0001209191-23-033772 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,480 Underlying: Ordinary Shares · 19,480 shares Expires 2033-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 4,870 on May 31, 2024; 4,870 on June 2, 2025; 4,870 on June 1, 2026 and 4,870 on June 1, 2027. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033772 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,067 F2 · balance_after: As of May 31, 2023, 11,422 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 1,157 on May 31, 2024; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 249 | $199.97 | $49,792.53 |
DisclosureSEC source: 0001209191-23-033772 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,596 F1 · shares: 249 shares were withheld from the 834 restricted shares that vested on May 31, 2023. These 249 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 834 ordinary shares were awarded to Mr. Zangerle on May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2023. F2 · balance_after: As of May 31, 2023, 11,422 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 1,157 on May 31, 2024; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 91 | $170.07 | $15,476.37 |
DisclosureSEC source: 0001209191-22-052761 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,845 F1 · shares: 91 shares were withheld from the 202 restricted shares that vested on October 3, 2022. These 91 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 202 ordinary shares were awarded to Mr. Zangerle on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 3, 2022. F2 · balance_after: As of October 5, 2022, 8,785 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,659 | $205.31 | $545,919.29 |
DisclosureSEC source: 0001209191-22-037903 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,936 F1 · shares: This sale of 2,659 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. F2 · balance_after: As of June 15, 2022, 8,987 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:57 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 15,372 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034152 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,372 Underlying: Ordinary Shares · 15,372 shares Expires 2032-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,843 on June 2, 2023, 3,843 on June 3, 2024, 3,843 on June 2, 2025 and 3,843 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:57 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034152 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,963 F2 · shares: As of June 2, 2022, 9,806 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. F2 · balance_after: As of June 2, 2022, 9,806 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 368 | $227.32 | $83,653.76 |
DisclosureSEC source: 0001209191-22-034531 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,595 F1 · shares: 368 shares were withheld from the 819 restricted shares that vested on June 2, 2022. These 368 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 819 ordinary shares were awarded to Mr. Zangerle on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2022. F2 · balance_after: As of June 6, 2022, 8,987 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:57 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 675 | $221.46 | $149,485.50 |
DisclosureSEC source: 0001209191-22-034152 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,579 F1 · shares: 675 shares were withheld from the 1,504 restricted shares that vested on June 1, 2022. These 675 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,504 ordinary shares were awarded to Mr. Zangerle on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022. F2 · balance_after: As of June 2, 2022, 9,806 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:02 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 2,769 | $228.20 | $631,885.80 |
DisclosureSEC source: 0001209191-22-033698 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,254 F1 · shares: 2,769 shares were withheld from the 6,138 restricted shares that vested on May 31, 2022. These 2,769 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 6,138 ordinary shares were awarded to Mr. Zangerle on May 31, 2018 and May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 7,926 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:30 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $67.98 | $0.00 |
DisclosureSEC source: 0001209191-22-025176 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. F4 · derivative.exercise_date: This option to purchase 8,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 8,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:30 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 8,000 | $255.48 | $2,043,876.00 |
DisclosureSEC source: 0001209191-22-025176 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,023 F1 · shares: This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $255.48 to $255.54 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,138 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:30 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 8,000 | $67.98 | $543,840.00 |
DisclosureSEC source: 0001209191-22-025176 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. F2 · balance_after: 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,138 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:04 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 8,196 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059554 · doc4.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,196 Underlying: Ordinary Shares · 8,196 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,049 on October 3, 2022; 2,049 on October 2, 2023; 2,049 on October 1, 2024 and 2,049 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:04 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059554 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,023 F1 · shares: All 808 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 3, 2022; 202 on October 2, 2023; 202 on October 1, 2024 and 202 on October 1, 2025. F2 · balance_after: 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 20:37 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 17,284 | $0.00 Strike: $210.30 | $0.00 |
DisclosureSEC source: 0001209191-21-037675 · doc4.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,284 Underlying: Ordinary Shares · 17,284 shares Expires 2031-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 4,321 on June 2, 2022; 4,321 on June 2, 2023; 4,321 on June 3, 2024 and 4,321 on June 2, 2025. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 20:37 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037675 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,215 F1 · shares: All 3,276 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 819 on June 2, 2022; 819 on June 2, 2023; 819 on June 3, 2024 and 819 on June 2, 2025. F2 · balance_after: 13,256 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024 and 819 on June 2, 2025. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:33 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 1,945 | $188.43 | $366,496.35 |
DisclosureSEC source: 0001209191-21-037201 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,939 F1 · shares: 1,945 shares were withheld from the 6,000 restricted shares that vested on June 1, 2021. These 1,945 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 6,000 ordinary shares were awarded to Mr. Zangerle on May 30, 2017. These vested shares were valued at the NYSE closing market price on June 1, 2021. F2 · balance_after: 9,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:35 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,252 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-20-053170 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,252 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 12,252 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 5, 2020. F3 · derivative.exercise_date: This option to purchase 12,252 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 12,252 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 12,252 | $178.00 | $2,180,856.00 |
DisclosureSEC source: 0001209191-20-053170 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,884 F1 · shares: This exercise and sale of a total of 12,252 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 5, 2020. F2 · balance_after: 15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:35 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 12,252 | $53.52 | $655,727.04 |
DisclosureSEC source: 0001209191-20-053170 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 12,252 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 5, 2020. F2 · balance_after: 15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.